The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
X-Linked Lymphoproliferative Disease
Open accessAbstract
2B4 is a surface molecule involved in activation of the natural killer (NK) cell–mediated cytotoxicity. It binds a protein termed Src homology 2 domain–containing protein (SH2D1A) or signaling lymphocyte activation molecule (SLAM)-associated protein (SAP), which in turn has been proposed to function as a regulator of the 2B4-associated signal transduction pathway. In this study, we analyzed patients with X-linked lymphoproliferative disease (XLP), a severe inherited immunodeficiency characterized by critical mutations in the SH2D1A gene and by the inability to control Epstein-Barr virus (EBV) infections. We show that, in these patients, 2B4 not only fails to transduce triggering signals, but also mediates a sharp inhibition of the NK-mediated cytolysis. Other receptors involved in NK cell triggering, including CD16, NKp46, NKp44, and NKp30, displayed a normal functional capability. However, their activating function was inhibited upon engagement of 2B4 molecules. CD48, the natural ligand of 2B4, is highly expressed on the surface of EBV+ B cell lines. Remarkably, NK cells from XLP patients could not kill EBV+ B cell lines. This failure was found to be the consequence of inhibitory signals generated by the interaction between 2B4 and CD48, as the antibody-mediated disruption of the 2B4–CD48 interaction restored lysis of EBV+ target cells lacking human histocompatibility leukocyte antigen (HLA) class I molecules. In the case of autologous or allogeneic (HLA class I+) EBV+ lymphoblastoid cell lines, restoration of lysis was achieved only by the simultaneous disruption of 2B4–CD48 and NK receptor–HLA class I interactions. Molecular analysis revealed that 2B4 molecules isolated from either XLP or normal NK cells were identical. As expected, in XLP-NK cells, 2B4 did not associate with SH2D1A, whereas similar to 2B4 molecules isolated from normal NK cells, it did associate with Src homology 2 domain–containing phosphatase 1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sayos, J., Wu, C., Morra, M., Wang, N., Zhang, X., Allen, D., van Schaik, S., Notarangelo, L., Geha, R., Roncarolo, M. G., et al. (1998) · Nature · doi:10.1038/26683 · Cited by 943
Self-citationPende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E., Accame, L., Malaspina, A., Biassoni, R., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1505 · Cited by 798
Self-citationCoffey, A. J., Brooksbank, R. A., Brandau, O., Oohashi, T., Howell, G. R., Bye, J. M., Cahn, A. P., Durham, J., Heath, P., Wray, P., et al. (1998) · Nature Genetics · doi:10.1038/2424 · Cited by 754
Vitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2065 · Cited by 748
Self-citationPessino, A., Sivori, S., Bottino, C., Malaspina, A., Morelli, L., Moretta, L., Biassoni, R., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.953 · Cited by 579
Self-citationp46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation
Sivori, S., Vitale, M., Morelli, L., Sanseverino, L., Augugliaro, R., Bottino, C., Moretta, L., & Moretta, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1129 · Cited by 554
Self-citationInactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome
Nichols, K. E., Harkin, D. P., Levitz, S., Krainer, M., Kolquist, K. A., Genovese, C., Bernard, A., Ferguson, M., Zuo, L., Snyder, E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13765 · Cited by 498
A novel receptor involved in T-cell activation
Cocks, B. G., Chang, C.-C. J., Carballido, J. M., Yssel, H., de Vries, J. E., & Aversa, G. (1995) · Nature · doi:10.1038/376260a0 · Cited by 479
Cantoni, C., Bottino, C., Vitale, M., Pessino, A., Augugliaro, R., Malaspina, A., Parolini, S., Moretta, L., Moretta, A., & Biassoni, R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.787 · Cited by 452
Self-citationSivori, S., Pende, D., Bottino, C., Marcenaro, E., Pessino, A., Biassoni, R., Moretta, L., & Moretta, A. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199905)29:05<1656::aid-immu1656>3.0.co;2-1 · Cited by 422
Self-citation2B4, the Natural Killer and T Cell Immunoglobulin Superfamily Surface Protein, Is a Ligand for CD48
Brown, M. H., Boles, K., Anton van der Merwe, P., Kumar, V., Mathew, P. A., & Neil Barclay, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2083 · Cited by 415
Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis
Moretta, A., Biassoni, R., Bottino, C., Mingari, M. C., & Moretta, L. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01596-6 · Cited by 354
Self-citationX-Linked Lymphoproliferative Disease: Twenty-Five Years after the Discovery
Seemayer, T. A., Gross, T. G., Egeler, R. M., Pirruccello, S. J., Davis, J. R., Kelly, C. M., Okano, M., Lanyi, A., & Sumegi, J. (1995) · Pediatric Research · doi:10.1203/00006450-199510000-00001 · Cited by 297
Tangye, S. G., Lazetic, S., Woollatt, E., Sutherland, G. R., Lanier, L. L., & Phillips, J. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.6981 · Cited by 297
Primary immunodeficiency diseases. A molecular and genetic approach.
Shigeoka, A. O. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990903)86:1<92::aid-ajmg21>3.0.co;2-0 · Cited by 263
Activating interactions in human NK cell recognition: the role of 2B4-CD48
Nakajima, H., Cella, M., Langen, H., Friedlein, A., & Colonna, M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199905)29:05<1676::aid-immu1676>3.0.co;2-y · Cited by 242
Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes.
Valiante, N. M., & Trinchieri, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.4.1397 · Cited by 223
Downregulation of TAP1 in B Lymphocytes by Cellular and Epstein-Barr Virus–Encoded Interleukin-10
Zeidler, R., Eissner, G., Meissner, P., Uebel, S., Tampé, R., Lazis, S., & Hammerschmidt, W. (1997) · Blood · doi:10.1182/blood.v90.6.2390 · Cited by 204
Mathew, P. A., Garni-Wagner, B. A., Land, K., Takashima, A., Stoneman, E., Bennett, M., & Kumar, V (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.10.5328 · Cited by 202
Rowe, M., Khanna, R., Jacob, C. A., Argaet, V., Kelly, A., Powis, S., Belich, M., Groom‐Carter, D., Lee, S., Burrows, S. R., et al. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250536 · Cited by 191
Cutting Edge: Identification of the 2B4 Molecule as a Counter-Receptor for CD48
Latchman, Y. E., McKay, P. F., & Reiser, H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.5809 · Cited by 180
Identification of the 2B4 molecule as a counter-receptor for CD48.
Latchman, Y. E., McKay, P. F., & Reiser, H. (1998) · PubMed · Cited by 170
Cantoni, C., Bottino, C., Augugliaro, R., Morelli, L., Marcenaro, E., Castriconi, R., Vitale, M., Pende, D., Sivori, S., Millo, R., et al. (1999) · European Journal of Immunology · Cited by 153
Self-citationBottino, C., Biassoni, R., Millo, R., Moretta, L., & Moretta, A. (2000) · Human Immunology · doi:10.1016/s0198-8859(99)00162-7 · Cited by 108
Self-citationBolhuis, R. L. H., Roozemond, R. C., & van de Griend, R. J. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.11.3939 · Cited by 93
X-linked lymphoproliferative syndrome.
Jl, S., & Ba, W. (1989) · PubMed · Cited by 79
Okano, M., Pirruccello, S. J., Grierson, H. L., Johnson, D. R., Thiele, G. M., & Purtilo, D. T. (1990) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(90)90054-t · Cited by 46
Bischof, A. (2000) · doi:10.1002/1521-4141(200003)30:3
Cited by
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,778
Self-citationUp on the tightrope: natural killer cell activation and inhibition
Lanier, L. L. (2008) · Nature Immunology · doi:10.1038/ni1581 · Cited by 1,656
Natural killer cells, viruses and cancer
Cerwenka, A., & Lanier, L. L. (2001) · Nature Reviews Immunology · doi:10.1038/35095564 · Cited by 875
Cellular responses to viral infection in humans: lessons from Epstein–Barr virus
Hislop, A. D., Taylor, G. S., Sauce, D., & Rickinson, A. B. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141553 · Cited by 766
Metadata
- Authors
- Parolini, S., Bottino, C., Falco, M., Augugliaro, R., Giliani, S., Franceschini, R., Ochs, H. D., Wolf, H., Bonnefoy, J.-Y., Biassoni, R., Moretta, L., Notarangelo, L. D., & Moretta, A.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2000-07-31
- Volume
- 192
- Issue
- 3
- Pages
- 337-346
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2170419443
- Cited by
- 477
- References
- 28
- FWCI
- 13.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.